Inactive Instrument
Eurofins-Cerep Stock Euronext Paris
Stocks
FR0012413771
Biotechnology & Medical Research
| Market Cap | 86.76M 99.06M 80.07M 74.73M 141M 9.38B 143M 961M 373M 4.62B 372M 364M 16.1B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 65.72M 75.05M 60.66M 56.61M 107M 7.11B 108M 728M 282M 3.5B 282M 276M 12.2B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.01% |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 2024-04-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Ratcliffe
CHM | Chairman | - | 2023-08-10 |
Damien Vielliard
BRD | Director/Board Member | - | 2024-05-22 |
Rodolphe Simonot
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | +4,900.50% | - | - | 96.78M | |
| +1.15% | +9.07% | -3.67% | +4.36% | 46.62B | |
| -2.77% | +12.95% | +407.40% | +614.26% | 40.95B | |
| -0.03% | +15.14% | +22.70% | -12.74% | 32.26B | |
| -1.73% | +4.85% | +18.15% | +59.57% | 32.24B | |
| -3.29% | +2.85% | +13.80% | +30.30% | 25.53B | |
| +1.15% | +16.98% | - | - | 16.38B | |
| -0.96% | +16.22% | +70.46% | +125.41% | 15.27B | |
| +0.56% | +8.00% | +12.65% | +21.35% | 13.61B | |
| -1.74% | +4.48% | +99.22% | +92.87% | 13.34B | |
| Average | -0.77% | +10.33% | +80.09% | +116.92% | 26.24B | |
| Weighted average by Cap. | -0.90% | +10.36% | +94.41% | +141.41% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.23M 37.37M 34.87M 65.62M 4.38B 66.83M 448M 174M 2.16B 174M 170M 7.52B | 41.1M 46.93M 37.93M 35.4M 66.61M 4.44B 67.84M 455M 177M 2.19B 176M 172M 7.63B |
| Net income | 7.15M 8.17M 6.6M 6.16M 11.6M 774M 11.81M 79.22M 30.74M 381M 30.69M 30M 1.33B | 4.78M 5.46M 4.41M 4.12M 7.75M 517M 7.89M 52.95M 20.55M 255M 20.52M 20.05M 888M |
| Net Debt | -17.25M -19.7M -15.92M -14.86M -27.96M -1.87B -28.48M -191M -74.13M -920M -74.02M -72.35M -3.2B | -21.03M -24.02M -19.41M -18.12M -34.09M -2.27B -34.72M -233M -90.38M -1.12B -90.24M -88.2M -3.9B |
Employees
-
